vs

Side-by-side financial comparison of Invesco (IVZ) and Masco (MAS). Click either name above to swap in a different company.

Masco is the larger business by last-quarter revenue ($1.9B vs $1.7B, roughly 1.1× Invesco). Masco runs the higher net margin — 11.9% vs -58.9%, a 70.7% gap on every dollar of revenue. On growth, Masco posted the faster year-over-year revenue change (6.5% vs 6.2%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -4.2%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Masco Corporation is an American manufacturer of products for the home improvement and new home construction markets. Comprising more than 20 companies, the Masco conglomerate operates nearly 60 manufacturing facilities in the United States and over 20 in other parts of the world. Since 1969 it trades on the NYSE. Under the leadership of Richard Manoogian, the company grew exponentially and subsequently joined the Fortune 500 list of largest U.S. corporations.

IVZ vs MAS — Head-to-Head

Bigger by revenue
MAS
MAS
1.1× larger
MAS
$1.9B
$1.7B
IVZ
Growing faster (revenue YoY)
MAS
MAS
+0.3% gap
MAS
6.5%
6.2%
IVZ
Higher net margin
MAS
MAS
70.7% more per $
MAS
11.9%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-4.2%
MAS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IVZ
IVZ
MAS
MAS
Revenue
$1.7B
$1.9B
Net Profit
$-995.9M
$228.0M
Gross Margin
35.8%
Operating Margin
-86.2%
16.5%
Net Margin
-58.9%
11.9%
Revenue YoY
6.2%
6.5%
Net Profit YoY
-575.8%
14.5%
EPS (diluted)
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
MAS
MAS
Q1 26
$1.9B
Q4 25
$1.7B
$1.8B
Q3 25
$1.6B
$1.9B
Q2 25
$1.5B
$2.1B
Q1 25
$1.5B
$1.8B
Q4 24
$1.6B
$1.8B
Q3 24
$1.5B
$2.0B
Q2 24
$1.5B
$2.1B
Net Profit
IVZ
IVZ
MAS
MAS
Q1 26
$228.0M
Q4 25
$-995.9M
$165.0M
Q3 25
$356.4M
$189.0M
Q2 25
$197.4M
$270.0M
Q1 25
$171.1M
$186.0M
Q4 24
$209.3M
$182.0M
Q3 24
$55.0M
$167.0M
Q2 24
$132.2M
$258.0M
Gross Margin
IVZ
IVZ
MAS
MAS
Q1 26
35.8%
Q4 25
33.9%
Q3 25
34.2%
Q2 25
37.6%
Q1 25
35.8%
Q4 24
34.8%
Q3 24
36.6%
Q2 24
37.5%
Operating Margin
IVZ
IVZ
MAS
MAS
Q1 26
16.5%
Q4 25
-86.2%
13.8%
Q3 25
16.5%
15.8%
Q2 25
14.1%
20.1%
Q1 25
18.1%
15.9%
Q4 24
19.6%
15.9%
Q3 24
6.6%
18.0%
Q2 24
13.9%
19.0%
Net Margin
IVZ
IVZ
MAS
MAS
Q1 26
11.9%
Q4 25
-58.9%
9.2%
Q3 25
21.7%
9.9%
Q2 25
13.0%
13.2%
Q1 25
11.2%
10.3%
Q4 24
13.1%
10.0%
Q3 24
3.6%
8.4%
Q2 24
8.9%
12.3%
EPS (diluted)
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
$-2.61
$0.81
Q3 25
$0.66
$0.90
Q2 25
$-0.03
$1.28
Q1 25
$0.38
$0.87
Q4 24
$0.46
$0.85
Q3 24
$0.12
$0.77
Q2 24
$0.29
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
MAS
MAS
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$1.8B
$2.9B
Stockholders' EquityBook value
$12.2B
$27.0M
Total Assets
$27.1B
$5.2B
Debt / EquityLower = less leverage
0.15×
109.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
$1.0B
$647.0M
Q3 25
$973.1M
$559.0M
Q2 25
$922.7M
$390.0M
Q1 25
$821.7M
$377.0M
Q4 24
$986.5M
$634.0M
Q3 24
$1.0B
$646.0M
Q2 24
$878.5M
$398.0M
Total Debt
IVZ
IVZ
MAS
MAS
Q1 26
$2.9B
Q4 25
$1.8B
$2.9B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
$2.9B
Q3 24
$890.3M
Q2 24
$890.1M
Stockholders' Equity
IVZ
IVZ
MAS
MAS
Q1 26
$27.0M
Q4 25
$12.2B
$-185.0M
Q3 25
$14.0B
$-78.0M
Q2 25
$13.9B
$-84.0M
Q1 25
$14.7B
$-254.0M
Q4 24
$14.6B
$-279.0M
Q3 24
$14.8B
$-88.0M
Q2 24
$14.6B
$-26.0M
Total Assets
IVZ
IVZ
MAS
MAS
Q1 26
$5.2B
Q4 25
$27.1B
$5.2B
Q3 25
$28.4B
$5.3B
Q2 25
$28.5B
$5.3B
Q1 25
$28.1B
$5.1B
Q4 24
$27.0B
$5.0B
Q3 24
$27.5B
$5.3B
Q2 24
$27.2B
$5.4B
Debt / Equity
IVZ
IVZ
MAS
MAS
Q1 26
109.07×
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
MAS
MAS
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
1.4%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
$455.8M
$418.0M
Q3 25
$606.2M
$456.0M
Q2 25
$547.9M
$306.0M
Q1 25
$-84.6M
$-158.0M
Q4 24
$316.9M
$407.0M
Q3 24
$438.4M
$416.0M
Q2 24
$489.1M
$346.0M
Free Cash Flow
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
$432.2M
$371.0M
Q3 25
$586.4M
$415.0M
Q2 25
$530.4M
$270.0M
Q1 25
$-108.0M
$-190.0M
Q4 24
$309.9M
$351.0M
Q3 24
$410.0M
$378.0M
Q2 24
$462.4M
$303.0M
FCF Margin
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
25.5%
20.7%
Q3 25
35.7%
21.6%
Q2 25
35.0%
13.2%
Q1 25
-7.1%
-10.5%
Q4 24
19.5%
19.2%
Q3 24
27.1%
19.1%
Q2 24
31.2%
14.5%
Capex Intensity
IVZ
IVZ
MAS
MAS
Q1 26
1.8%
Q4 25
1.4%
2.6%
Q3 25
1.2%
2.1%
Q2 25
1.2%
1.8%
Q1 25
1.5%
1.8%
Q4 24
0.4%
3.1%
Q3 24
1.9%
1.9%
Q2 24
1.8%
2.1%
Cash Conversion
IVZ
IVZ
MAS
MAS
Q1 26
Q4 25
2.53×
Q3 25
1.70×
2.41×
Q2 25
2.78×
1.13×
Q1 25
-0.49×
-0.85×
Q4 24
1.51×
2.24×
Q3 24
7.97×
2.49×
Q2 24
3.70×
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

MAS
MAS

Segment breakdown not available.

Related Comparisons